3122.0: Monday, November 13, 2000: 2:30 PM-4:00 PM | ||||
| ||||
| This session will discuss the scientific basis and cost effectiveness of regulatory policy | ||||
| See individual abstracts for presenting author's disclosure statement. | ||||
| Learning Objectives: Refer to the individual abstracts for learning objectives | ||||
| Effect of clinical laboratory equipment and personnel on patient outcomes following prothrombin time testing Stephen T. Mennemeyer, PhD, James W Winkelman, MD, Catarina I Kiefe, MD | ||||
| Economic impact of Federal regulations on laboratory indirect and opportunity costs Eleanor Travers, MD | ||||
| Use of the National Inventory of Clinical Laboratory Testing Services to Predict the Impact of Service Changes on Laboratory Testing Patterns Ana K. Stankovic, MDPhD, Steven J. Steindel, PhD, Stephen T. Mennemeyer, PhD | ||||
| Recent trends in clinical laboratory fees and expenditures Zachary Dyckman, PhD | ||||
| Sponsor: | Laboratory Section | |||